Mechanisms of nonsteroidal anti-inflammatory drugs in cancer prevention.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Seminars in Oncology

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.seminoncol.2015.09.010PMID 26970125
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer

  2016cited by this paper
• PCORI approves trial to determine best aspirin dose to help heart disease patients

  2015cited by this paper
• Cutting Edge: Maresin-1 Engages Regulatory T Cells To Limit Type 2 Innate Lymphoid Cell Activation and Promote Resolution of Lung Inflammation

  2015cited by this paper
• Prediction of Renal Transporter Mediated Drug-Drug Interactions for Pemetrexed Using Physiologically Based Pharmacokinetic Modeling

  2015cited by this paper
• Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.

  2015cited by this paper
• Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.

  2015cited by this paper
• Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation

  2015cited by this paper
• Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.

  2015cited by this paper
• Characterisation of the influences of aspirin-acetylation and glycation on human plasma proteins.

  2015cited by this paper
• Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP)

  2015cited by this paper
• Dendritic cell immunotherapy: clinical outcomes

  2014cited by this paper
• Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention.

  2014cited by this paper
• Characterization of microsomal prostaglandin E synthase 1 inhibitors.

  2014cited by this paper
• NK cells and T cells cooperate during the clinical course of colorectal cancer

  2014cited by this paper
• Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.

  2014cited by this paper
• Dynamics of adenylate cyclase regulation via heterotrimeric G-proteins.

  2014cited by this paper
• Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies

  2014cited by this paper
• Estimates of benefits and harms of prophylactic use of aspirin in the general population

  2014cited by this paper
• Platelets and cancer: a casual or causal relationship: revisited

  2014cited by this paper
• Platelets, cyclooxygenases, and colon cancer.

  2014cited by this paper
• Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD)

  2014cited by this paper
• Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology

  2014cited by this paper
• Pro-resolving lipid mediators are leads for resolution physiology

  2014cited by this paper
• Role of inflammation and inflammatory mediators in colorectal cancer.

  2014cited by this paper
• Aspirin in gastrointestinal oncology: new data on an old friend

  2014cited by this paper
• Selective COX-2 inhibitors suppress prostacyclin.

  2014cited by this paper
• Inactivating Mutation in the Prostaglandin Transporter Gene, SLCO2A1, Associated with Familial Digital Clubbing, Colon Neoplasia, and NSAID Resistance

  2014cited by this paper
• Mechanistic Insights into a Classic Wonder Drug—Aspirin

  2014cited by this paper
• Role of platelets in inflammation and cancer: novel therapeutic strategies.

  2014cited by this paper
• A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.

  2014cited by this paper
• Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

  2014cited by this paper
• Reappraisal of the clinical pharmacology of low‐dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action

  2014cited by this paper
• The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.

  2014cited by this paper
• Alternate-Day, Low-Dose Aspirin and Cancer Risk

  2013cited by this paper
• Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.

  2013cited by this paper
• CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis.

  2013cited by this paper
• Janus Kinase 3 Activity Is Necessary for Phosphorylation of Cytosolic Phospholipase A2 and Prostaglandin E2 Synthesis by Macrophages Infected with Francisella tularensis Live Vaccine Strain

  2013cited by this paper
• A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis

  2013cited by this paper
• Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer

  2013cited by this paper
• Clinical features of gastroduodenal injury associated with long-term low-dose aspirin therapy.

  2013cited by this paper
• Aspirin in prevention of sporadic colorectal cancer: current clinical evidence and overall balance of risks and benefits.

  2013cited by this paper
• Aspirin, PIK3CA mutation, and colorectal-cancer survival.

  2013cited by this paper
• DNA methyl transferase I acts as a negative regulator of allergic skin inflammation.

  2013cited by this paper
• Urinary PGE-M: A Promising Cancer Biomarker

  2013cited by this paper
• Prostaglandin E2 Regulates Pancreatic Stellate Cell Activity Via the EP4 Receptor

  2013cited by this paper
• An Inflammatory Mediator, Prostaglandin E2, in Colorectal Cancer

  2013cited by this paper
• Aspirin use and risk of colorectal cancer according to BRAF mutation status.

  2013cited by this paper
• Direct regulation of caspase‑3 by the transcription factor AP‑2α is involved in aspirin‑induced apoptosis in MDA‑MB‑453 breast cancer cells.

  2013cited by this paper
• Direct Measurements of Human Colon Crypt Stem Cell Niche Genetic Fidelity: The Role of Chance in Non-Darwinian Mutation Selection

  2013cited by this paper
• Aspirin, PIK3CA mutation, and colorectal-cancer survival.

  2013cited by this paper
• The Prostanoid EP4 Receptor and Its Signaling Pathway

  2013cited by this paper
• New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.

  2013cited by this paper
• E-type prostanoid receptor 4 (EP4) in disease and therapy

  2013cited by this paper
• Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

  2013cited by this paper
• Alternate-Day, Low-Dose Aspirin and Cancer Risk: Long-Term Observational Follow-up of a Randomized Trial

  2013cited by this paper
• Lipidomic profiling of bioactive lipids by mass spectrometry during microbial infections.

  2013cited by this paper
• Biological markers: Potential biomarker for aspirin use in colorectal cancer therapy

  2013cited by this paper
• Murine mPGES-1 3D Structure Elucidation and Inhibitors Binding Mode Predictions by Homology Modeling and Site-Directed Mutagenesis

  2013cited by this paper
• Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

  2012cited by this paper
• Is 15-LOX-1 a tumor suppressor?

  2012cited by this paper
• Complement-mediated Activation of Calcium-independent Phospholipase A2γ

  2012cited by this paper
• The inflammatory network in the gastrointestinal tumor microenvironment: lessons from mouse models

  2012cited by this paper
• The shunting of arachidonic acid metabolism to 5-lipoxygenase and cytochrome p450 epoxygenase antagonizes the anti-cancer effect of cyclooxygenase-2 inhibition in head and neck cancer cells

  2012cited by this paper
• Aspirin and cancer risk: a quantitative review to 2011.

  2012cited by this paper
• Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia

  2012cited by this paper
• Are we ready to recommend aspirin for cancer prevention?

  2012cited by this paper
• Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials.

  2012cited by this paper
• Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

  2012cited by this paper
• Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.

  2012cited by this paper
• Effects of Celecoxib on Prostanoid Biosynthesis and Circulating Angiogenesis Proteins in Familial Adenomatous Polyposis

  2012cited by this paper
• Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas

  2012cited by this paper
• Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4

  2012cited by this paper
• Cyclooxygenase/lipoxygenase shunting lowers the anti-cancer effect of cyclooxygenase-2 inhibition in colorectal cancer cells

  2012cited by this paper
• Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent

  2012cited by this paper
• Advances in prevention and health services delivery 2010-2011.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Gene expression analysis of membrane transport proteins in normal and lipopolysaccharide-inflamed rat dental pulp.

  2012cited by this paper
• Prostaglandins in Cancer Cell Adhesion, Migration, and Invasion

  2012cited by this paper
• Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.

  2012cited by this paper
• Daily aspirin use and cancer mortality in a large US cohort.

  2012cited by this paper
• Matrix Metalloproteinase-Dependent Microsomal Prostaglandin E Synthase-1 Expression in Macrophages: Role of TNF-α and the EP4 Prostanoid Receptor

  2012cited by this paper
• PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells

  2012cited by this paper
• Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice.

  2012cited by this paper
• The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial

  2011cited by this paper
• Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

  2011cited by this paper
• Abstract 89: Prostaglandin E2 promotes intestinal tumor growth via DNA methylation

  2011cited by this paper
• COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

  2011cited by this paper
• Glucocorticoid receptor signaling and prostate cancer.

  2011cited by this paper
• Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention

  2011cited by this paper
• Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4

  2011cited by this paper
• Different Phenotypic Consequences of Simultaneous Versus Stepwise Apc Loss

  2011cited by this paper
• Tumor necrosis factor-related genes and colon and rectal cancer.

  2011cited by this paper
• Prostaglandin E2 and SOCS1 have a role in intestinal immune tolerance

  2011cited by this paper
• Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial.

  2011cited by this paper
• A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis

  2011cited by this paper
• Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).

  2011cited by this paper
• Platelets as immune mediators: their role in host defense responses and sepsis.

  2011cited by this paper
• Aspirin acetylates multiple cellular proteins in HCT-116 colon cancer cells: Identification of novel targets.

  2011cited by this paper

• Non‐steroidal anti‐inflammatory medication use and endometrial cancer survival: A population‐based Norwegian cohort study

  2025cites this paper
• Flavanones: bioavailability and role in modulation of oxidative stress and inflammation in cancer, type-2 diabetes, and cardiovascular diseases

  2025cites this paper
• Association of non-steroidal anti-inflammatory medications and aspirin with colorectal cancer incidence in older adults

  2025cites this paper
• Plausible Action of N‐(3,4‐Dimethoxy‐Phenyl)‐6,7‐Dimethoxyquinazoline‐4‐Amine (TKM01) as an Armor Against Alzheimer's Disease: In Silico and In Vivo Insights

  2024cites this paper
• Flurbiprofen axetil is involved in basal‐like breast cancer metastasis via suppressing the MEK/ERK signaling pathway

  2024cites this paper
• Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development

  2022cites this paper
• Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies

  2022cites this paper
• Resolution of inflammation: An organizing principle in biology and medicine.

  2021cites this paper
• NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future.

  2021cites this paper
• α-Conotoxins and α-Cobratoxin Promote, while Lipoxygenase and Cyclooxygenase Inhibitors Suppress the Proliferation of Glioma C6 Cells

  2021cites this paper
• Non-aspirin NSAID use and mortality of endometrial cancer. A nationwide cohort study

  2021cites this paper
• A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant Chemotherapy

  2021cites this paper
• Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors

  2021cites this paper
• Role of platelets and breast cancer stem cells in metastasis

  2020cites this paper
• Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk

  2020cites this paper
• Drug Repurposing Approaches: Existing Leads For Novel Threats And Drug Targets.

  2020cites this paper
• Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation

  2020cites this paper
• Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs

  2020cites this paper
• Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer—What Can We Learn from the Hematological Experience?

  2020cites this paper
• Effect of Aspirin on Cancer Incidence and Mortality in Older Adults

  2020cites this paper
• Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders.

  2020cites this paper
• New drugs are not enough-drug repositioning in oncology: An update

  2020cites this paper
• Potential applications of multifunctional mesoporous carbon nanoplatform for tumor microenvironment improving by combined chemo-/phototherapy

  2020cites this paper
• Tumor Microenvironment: Molecular Players – Part A

  2020cites this paper
• Fatty Acid Mediators in the Tumor Microenvironment.

  2020cites this paper
• Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial

  2020cites this paper
• Potentiation of TRAIL-induced cell death by nonsteroidal anti-inflammatory drug in human hepatocellular carcinoma cells through the ER stress-dependent autophagy pathway

  2020cites this paper
• Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts

  2020cites this paper
• Associations between daily aspirin use and cancer risk across strata of major cancer risk factors in two large U.S. cohorts

  2020cites this paper
• Diclofenac Enhances Docosahexaenoic Acid-Induced Apoptosis in Vitro in Lung Cancer Cells

  2020cites this paper
• Low-dose aspirin use and endometrial cancer mortality-a Danish nationwide cohort study.

  2019cites this paper
• Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology.

  2019cites this paper
• PPARγ Agonists in Combination Cancer Therapies.

  2019cites this paper
• Evaluation of potential drug-drug interactions in patients with hematologic malignancies at a referral hematology–oncology hospital: A single-center experience

  2019cites this paper
• In Vitro and In Vivo Evaluation of the Anticancer and Anti-inflammatory Activities of 2-Himachelen-7-ol isolated from Cedrus Libani

  2019cites this paper
• Docosahexaenoic acid-flurbiprofen combination ameliorates metaflammation in rats fed on high-carbohydrate high-fat diet.

  2019cites this paper
• Aspirin-triggered proresolving mediators stimulate resolution in cancer

  2019cites this paper
• Short term supplementation of celecoxib shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation

  2019cites this paper
• Urinary PGE-M Levels and Risk of Ovarian Cancer

  2019cites this paper
• Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer

  2019cites this paper
• The Effect of Aspirin and Ibuprofen on the Proliferation of Cervical Cancer Cells (HeLa) Compared to Non-Cancerous Cells (HEK 293) in Cell Culture Medium

  2018cites this paper
• Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine

  2018cites this paper
• Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study

  2018cites this paper
• NSAID use and somatic exomic mutations in Barrett’s esophagus

  2018cites this paper
• Sensitization of multidrug-resistant cancer cells to Hsp90 inhibitors by NSAIDs-induced apoptotic and autophagic cell death

  2018cites this paper
• The effectiveness of cyclooxygenase-2 inhibitors and evaluation of angiogenesis in the model of experimental colorectal cancer.

  2018cites this paper
• Chemoprevention with phosphatidylcholine non-steroidal anti-inflammatory drugs in vivo and in vitro.

  2018cites this paper
• pH-sensitive inulin-based nanomicelles for intestinal site-specific and controlled release of celecoxib.

  2018cites this paper
• Utility of inverse probability weighting in molecular pathological epidemiology

  2018cites this paper
• Aspirin use and endometrial cancer risk and survival.

  2018cites this paper
• NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies

  2018cites this paper
• Non-aspirin NSAID use and ovarian cancer mortality.

  2018cites this paper
• Antagonism between salicylate and the cAMP signal controls yeast cell survival and growth recovery from quiescence

  2018cites this paper
• Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level.

  2018cites this paper
• Bioactive lipid metabolism in platelet “first responder” and cancer biology

  2018cites this paper
• Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses’ Health Studies

  2018cites this paper
• Perioperative biobehavioral interventions to prevent cancer recurrence through combined inhibition of β‐adrenergic and cyclooxygenase 2 signaling

  2018cites this paper
• Anti-Inflammatory Drug Use and Ovarian Cancer Risk by COX1/COX2 Expression and Infiltration of Tumor-Associated Macrophages

  2018cites this paper
• NSAIDs for the Prevention and Control of Lethal Prostate Cancer

  2018cites this paper
• Metamizole (dipyrone) – cytotoxic and antiproliferative effects on HeLa, HT-29 and MCF-7 cancer cell lines

  2018cites this paper
• Impact of an anti-metabolic therapy on leukemic and non-malignant T cells

  2018cites this paper
• Regulation of HPGD and SLCO2A1 in colorectal cancer development

  2018influential citation
• Cancer Prevention in the Era of Precision Oncology

  2017cites this paper
• Platelets: “First Responders” in Cancer Progression and Metastasis

  2017cites this paper
• Drug repurposing in cancer.

  2017cites this paper
• Association Between Inflammatory Diet Pattern and Risk of Colorectal Carcinoma Subtypes Classified by Immune Responses to Tumor.

  2017cites this paper
• Antiplatelet agents for cancer treatment: a real perspective or just an echo from the past?

  2017cites this paper
• Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology

  2017cites this paper
• European Medicines Agency Perspective on Oncology Study Design for Marketing Authorization and Beyond

  2017cites this paper
• Natural remedies for non‐steroidal anti‐inflammatory drug‐induced toxicity

  2017cites this paper
• Platelet “first responders” in wound response, cancer, and metastasis

  2017cites this paper
• Influence of aspirin and non-aspirin NSAID use on ovarian and endometrial cancer: Summary of epidemiologic evidence of cancer risk and prognosis.

  2017cites this paper
• Prevention and treatment of cancer targeting chronic inflammation: research progress, potential agents, clinical studies and mechanisms

  2017cites this paper
• Nutrigenomics, Epigenetics and Pain in Cancer

  2017cites this paper
• Side effects of pain and analgesia in animal experimentation

  2017cites this paper
• Duration of Dual Antiplatelet Therapy After Coronary Stenting.

  2016cites this paper
• Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.

  2016cites this paper
• Use of Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Relation to Cardiovascular Events. A Systematic Pharmacoepidemiological Review.

  2016cites this paper
• Cancer Prevention and Interception: A New Era for Chemopreventive Approaches

  2016cites this paper
• The Combined Blockade of &bgr;-Adrenoceptor and COX-2 During the Perioperative Period to Improve Long-term Cancer Outcomes

  2016cites this paper
• Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets

  2016cites this paper
• Novel NSAID-Derived Drugs for the Potential Treatment of Alzheimer’s Disease

  2016cites this paper
• Cancer Prevention: Lessons Learned and Future Directions.

  2016cites this paper
• Chemoprevention : Using Drugs and Nutrients to Decrease Cancer Risk

  2016cites this paper